These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 10707832)
21. Prostate specific antigen reference ranges in Saudi men. Kamal BA; Ali GA; Taha SA Saudi Med J; 2003 Jun; 24(6):665-8. PubMed ID: 12847600 [TBL] [Abstract][Full Text] [Related]
22. Correlation of serum prostate specific antigen and quantitative immunohistochemistry. Weir EG; Partin AW; Epstein JI J Urol; 2000 Jun; 163(6):1739-42. PubMed ID: 10799172 [TBL] [Abstract][Full Text] [Related]
23. [Alpha2-macroglobulin in various pathological conditions of the prostate]. Karseladze AI; Rytin IE; Kulevich EE Arkh Patol; 2005; 67(1):33-6. PubMed ID: 15822792 [TBL] [Abstract][Full Text] [Related]
24. Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer? Williams SA; Singh P; Isaacs JT; Denmeade SR Prostate; 2007 Feb; 67(3):312-29. PubMed ID: 17143882 [TBL] [Abstract][Full Text] [Related]
25. [Prostate-specific antigen (PSA) in women]. Kamenov Z; Todorova M; Khristov V Vutr Boles; 2001; 33(1):40-7. PubMed ID: 11785088 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients. Grande M; Carlström K; Rozell BL; Stege R; Pousette A Clin Cancer Res; 2000 May; 6(5):1790-5. PubMed ID: 10815899 [TBL] [Abstract][Full Text] [Related]
27. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196 [TBL] [Abstract][Full Text] [Related]
28. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men. Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477 [TBL] [Abstract][Full Text] [Related]
29. Isolation of human prostatic epithelial plasma membranes for proteomics using mirror image tissue banking of radical prostatectomy specimens. Sircar K; Gaboury L; Ouadi L; Mecteau M; Scarlata E; Saad F; Aprikian A; Tanguay S; Lapointe S; Lussier C; Miletti T; Lanoix J Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4178-84. PubMed ID: 16857789 [TBL] [Abstract][Full Text] [Related]
30. Derivatives of prostate-specific antigen as predictors of incidental prostate cancer. Froehner M; Buck LM; Koch R; Hakenberg OW; Wirth MP BJU Int; 2009 Jul; 104(1):25-8. PubMed ID: 19191782 [TBL] [Abstract][Full Text] [Related]
31. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis. Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862 [TBL] [Abstract][Full Text] [Related]
33. Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology. Varma M; Morgan M; Jasani B; Tamboli P; Amin MB Am J Clin Pathol; 2002 Aug; 118(2):202-7. PubMed ID: 12162678 [TBL] [Abstract][Full Text] [Related]
34. Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients. Wang Y; Harada M; Yano H; Ogasawara S; Tanaka M; Yamada A; Itoh K Oncol Rep; 2006 Feb; 15(2):317-21. PubMed ID: 16391848 [TBL] [Abstract][Full Text] [Related]
35. Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer. Elkord E; Williams PE; Kynaston H; Rowbottom AW Int Immunol; 2005 Oct; 17(10):1315-25. PubMed ID: 16141246 [TBL] [Abstract][Full Text] [Related]
36. [Gleason histologic grading of prostate carcinoma in relation to serum PSA, PSA in situ and immunohistochemical expression of 34 beta E12 and P504S]. Xiao Q; Yin H; Lu Z; Meng K; Zhou X Zhonghua Nan Ke Xue; 2004 May; 10(5):362-5. PubMed ID: 15190830 [TBL] [Abstract][Full Text] [Related]
37. [Prostate-specific antigen in serum and prostate epithelium in benign prostatic hyperplasia]. Papava VL; Kochiashvili DK; Chovelidze ShG; Khardzeishvili OM Georgian Med News; 2007 Feb; (143):73-6. PubMed ID: 17404446 [TBL] [Abstract][Full Text] [Related]
38. Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer. Hautmann S; Huland E; Grupp C; Haese A; Huland H Anticancer Res; 2000; 20(3B):2151-4. PubMed ID: 10928169 [TBL] [Abstract][Full Text] [Related]
39. Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years. Sun L; Moul JW; Hotaling JM; Rampersaud E; Dahm P; Robertson C; Fitzsimons N; Albala D; Polascik TJ BJU Int; 2007 Apr; 99(4):753-7. PubMed ID: 17244286 [TBL] [Abstract][Full Text] [Related]
40. Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review. Qiu YQ; Leuschner I; Braun PM Asian J Androl; 2008 Nov; 10(6):855-63. PubMed ID: 18958349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]